CITTERIO STEFANIA

Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine. BLOOD, 136(Supplement_2), LBA-5-LBA-5 [10.1182/BLOOD-2020-143852]. Detail

Mologni, L., Costanza, M., Sharma, G., Viltadi, M., Massimino, L., Citterio, S., et al. (2018). Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells. NEOPLASIA, 20(5), 467-477 [10.1016/j.neo.2018.02.009]. Detail

Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION. Intervento presentato a: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy. Detail

Fumagalli, S., Torri, A., Papagna, A., Citterio, S., Mainoldi, F., Foti, M. (2016). IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. SCIENTIFIC REPORTS, 6 [10.1038/srep33900]. Detail

Sharma, N., Magistroni, V., Piazza, R., Citterio, S., Mezzatesta, C., Khandelwal, P., et al. (2015). BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene. MOLECULAR CANCER, 14(1) [10.1186/s12943-015-0407-0]. Detail